Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy

Macromolecular Bioscience

Volumn 11, Issue 7, 2011, Pages 905-913

  Zorzi, Giovanni Konat ^a   Párraga, Jenny Evelin ^a   Seijo, Begoña ^a   Sánchez, Alejandro ^a  

^a Universidade de Santiago de Compostela   (Spain)

Author keywords

Drug delivery systems; Gelation; Nanoparticles; Nanotechnology

Indexed keywords

AVERAGE SIZE; CATIONIZED; CHONDROITIN SULFATES; CROSSLINKER; DEXTRAN SULFATES; DRUG DELIVERY SYSTEM; GELATIN NANOPARTICLES; HUMAN CORNEAL; HYBRID NANOPARTICLE; IN-VITRO; NANOMEDICINES; PHYSICOCHEMICAL PROPERTY; PLASMID DNA; POLYANIONS; TRANSFECTION EFFICIENCY;

COAGULATION; DEXTRAN; DRUG DELIVERY; GELATION; GENETIC ENGINEERING; NANOPARTICLES; TOXICITY; ZETA POTENTIAL;

GENE THERAPY;

CATION; CHONDROITIN SULFATE; DEOXYRIBONUCLEASE I; DEXTRAN; DEXTRAN SULPHATE; GELATIN; NANOPARTICLE; PLASMID DNA; POLYANION; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; CORNEA CELL; CROSS LINKING; CYTOTOXICITY; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYBRID; IN VITRO GENE TRANSFER; PHYSICOCHEMICAL MODEL; TOXICITY; ZETA POTENTIAL;

ANIONS; CATIONS; CELLS, CULTURED; CHONDROITIN SULFATES; CORNEA; DEOXYRIBONUCLEASE I; DEXTRAN SULFATE; DNA; GELATIN; GENE THERAPY; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PLASMIDS; POLYMERS; TRANSFECTION;

EID: 79959848036     PISSN: 16165187     EISSN: 16165195     Source Type: Journal    
DOI: 10.1002/mabi.201100005     Document Type: Article

References (44)

1. K. Csaky, R. Nussenblatt, Springer Semin. Immunopathol. 1999, 21, 191.
2. P. Colella, G. Cotugno, A. Auricchio, Trends Mol. Med. 2009, 15, 23.
3. R. R. Mohan, A. Sharma, M. V. Netto, S. Sinha, S. E. Wilson, Prog. Retin. Eye Res. 2005, 24, 537.
4. E. A. Klausner, D. Peer, R. L. Chapman, R. F. Multack, S. V. Andurkar, J. Controlled Release 2007, 124, 107.
5. J. F. Coelho, P. C. Ferreira, P. Alves, R. Cordeiro, A. C. Fonseca, J. R. Góis, M. H. Gil, EPMA J. 2010, 1, 164.
6. M. de la Fuente, B. Seijo, M. J. Alonso, Invest Ophthalmol. Vis. Sci. 2008, 49, 2016.
7. Y. Fukunaka, K. Iwanaga, K. Morimoto, M. Kakemi, Y. Tabata, J. Controlled Release 2002, 80, 333.
8. T. Kushibiki, R. Tomoshige, Y. Fukunaka, M. Kakemi, Y. Tabata, J. Controlled Release. 2003, 90, 207.
9. T. Kushibiki, R. Tomoshige, K. Iwanaga, M. Kakemi, Y. Tabata, J. Controlled Release 2006, 112, 249.
10. X. Xu, R. M. Capito, M. Spector, J. Biomed. Mater. Res. 2008, 84, 73.
11. J. E. Párraga, G. K. Zorzi, B. Seijo, A. Sánchez, Human Gene Ther. 2009, 20, 1545.
12. M. de la Fuente, M. Raviña, P. Paolicelli, A. Sánchez, B. Seijo, M. J. Alonso, Adv. Drug Delivery Rev. 2010, 62, 100.
13. M. de la Fuente, B. Seijo, M. J. Alonso, Gene Ther. 2008, 15, 668.
14. E. Lu, S. Franzblau, H. Onyuksel, C. Popescu, J. Microencapsul. 2009, 26, 346.
15. D. F. Ranney, Biochem. Pharmacol. 2000, 59, 105.
16. A. Sánchez, B. Seijo, J. E. Párraga, G. K. Zorzi, P. Paolicelli (University of Santiago de Compostela) ES WO2010049562, 2009.
17. J. E. Scott, J. Anat. 1995, 187, 259.
18. H. Kawashima, Y. F. Li, N. Watanabe, J. Hirose, M. Hirose, M. Miyasaka, Int. Immun. 1999, 11, 393.
19. J. A. Weigel, R. C. Raymond, P. H. Weigel, Biochem. Biophys. Res. Commun. 2002, 294, 918.
20. J. A. Weigel, P. H. Weigel, Glycobiology 2003, 13, 129.
21. J. A. Weigel, P. H. Weigel, J. Biol. Chem. 2003, 278, 42802.
22. M. Raviña, E. Cubillo, D. Olmeda, R. Novoa-Carballal, E. Fernandez-Megia, R. Riguera, A. Sánchez, A. Cano, M. J. Alonso, Pharm. Res. 2010, 27, 2544.
23. M. de la Fuente, B. Seijo, M. J. Alonso, Macromol. Biosci. 2008, 8, 441.
24. C. E. Mora-Huertas, H. Fessi, A. Eleissaria, Int. J. Pharm. 2010, 385, 113.
25. L. Rabinovick-Guilatt, P. Couvreur, G. Lambert, C. Dubernet, J. Drug Target 2004, 12, 623.
26. R. Raman, V. Sasisekharan, R. Sasisekharan, Chem. Biol. 2005, 12, 267.
27. D. Sacco, E. Dellacherie, FEBS Lett. 1986, 199, 245.
28. X. Cai, S. Conley, M. Naash, Vision Res. 2007, 48, 319.
29. B. G. Feurstein, N. Pattabiraman, L. J. Marton, Proc. Natl. Acad. Sci. USA 1986, 83, 5948.
30. K. Kawabata, Y. Takakura, M. Hashida, Pharm. Res. 1995, 12, 825.
31. K. B. Green-Church, K. K. Nichols, N. M. Kleinholz, L. Zhang, J. J. Nichols, Mol. Vis. 2008, 14, 456.
32. T. N. Yusifov, A. R. Abduragimov, O. K. Gasymov, B. J. Glasgow, Biochem. J. 2000, 374, 815.
33. T. N. Yusifov, A. R. Abduragimov, K. Narsinh, O. K. Gasymov, B. J. Glasgow, Mol. Vis. 2008, 14, 180.
34. L. Zhou, R. W. Beuerman, Y. Foo, S. Liu, L. P. K. Ang, D. T. H. Tan, Ann. Acad. Med. 2006, 35, 400.
35. V. Vijayanathan, T. Thomas, T. Antony, A. Shirahata, T. J. Thomas, Nucleic Acids Res. 2004, 32, 127.
36. M. Kuosmanen, H. Poso, FEBS Lett. 1985, 179, 17.
37. A. Pingoud, C. Urbanke, J. Alves, H. J. Ehbrecht, M. Zabeau, C. Gualerzi, Biochemistry 1984, 23, 5697.
38. L. d'Agostino, M. Di Pietro, A. di Luccia, FEBS J. 2005, 272, 3777.
39. B. Loretza, A. Bernkop-Schnürch, Nanotoxicology 2007, 1, 139.
40. T. W. Prow, I. Bhutto, S. Y. Kim, R. Grebe, C. Merges, D. S. Mcleod, K. Uno, M. Mennon, L. Rodríguez, K. Leong, G. A. Lutty, Nanomedicine 2008, 4, 340.
41. W. Tiyaboonchai, J. Woiszwillo, C. R. Middaugh, Eur. J. Pharm. Sci. 2003, 19, 191.
42. I. Yenice, M. C. Mocan, E. Palaska, A. Bochot, E. Bilensoy, I. Vural, M. Irkec, A. A. Hincal, Exp. Eye Res. 2008, 87, 162.
43. A. del Pozo-Rodríguez, D. Delgado, M. A. Solinis, A. R. Gascon, J. L. Pedraz, Int. J. Pharm. 2008, 360, 177.
44. M. de la Fuente, B. Seijo, M. J. Alonso, Nanotechnology 2008, 19, Epub 075105.